These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12901693)

  • 1. A study of the effects of curing and storage conditions on controlled release diphenhydramine HCl pellets coated with Eudragit NE30D.
    Lin AY; Muhammad NA; Pope D; Augsburger LL
    Pharm Dev Technol; 2003 Aug; 8(3):277-87. PubMed ID: 12901693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30D.
    Lin AY; Muhammad NA; Pope D; Augsburger LL
    AAPS PharmSci; 2001; 3(2):E14. PubMed ID: 11741265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
    Guan T; Wang J; Li G; Tang X
    Pharm Dev Technol; 2011 Jun; 16(3):269-77. PubMed ID: 20214529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
    Tian L; Zhang Y; Tang X
    Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns.
    Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2003 May; 89(3):457-71. PubMed ID: 12737848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets.
    Zheng W; McGinity JW
    Drug Dev Ind Pharm; 2003 Mar; 29(3):357-66. PubMed ID: 12741617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eudragit NE40-drug mixed coating system for controlling drug release of core pellets.
    Rahman NU; Yuen KH
    Drug Dev Ind Pharm; 2005 May; 31(4-5):339-47. PubMed ID: 16093199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
    Wu C; McGinity JW
    Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the film formation of the dry coating process.
    Kablitz CD; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions.
    Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA
    Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and bioavailability of sustained-release doxofylline pellets in beagle dogs.
    Huang HF; Lu Y; He HB; Tang X
    Drug Dev Ind Pharm; 2008 Jul; 34(7):676-82. PubMed ID: 18608467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of curing conditions and plasticizer level on the release of highly lipophilic drug from coated multiparticulate drug delivery system.
    Hamed E; Sakr A
    Pharm Dev Technol; 2003; 8(4):397-407. PubMed ID: 14601964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of tablets containing enteric-coated diclofenac sodium pellets].
    Qi XL; Zhu JB; Chen SJ
    Yao Xue Xue Bao; 2008 Jan; 43(1):97-101. PubMed ID: 18357741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying a novel electrostatic dry powder coating technology to pellets.
    Yang Q; Ma Y; Zhu J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
    Maejima T; McGinity JW
    Pharm Dev Technol; 2001; 6(2):211-21. PubMed ID: 11416995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.